Insightfil Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

Insightfil General Information

Description

Provider of a medication adherence platform intended for the healthcare industry. The company's platform allows automated dispensing of pills according to doctor's prescription and a reminder system to ensure adherence, enabling patients and caregivers to not miss any dosage leading to better healthcare outcomes. .

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Application Software
Primary Office
  • 1 Design Center Place
  • Suite 644
  • Boston, MA 02210
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Insightfil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 13-Dec-2016 0000 Completed Startup
5. Accelerator/Incubator 0000 Completed Startup
4. Grant 00000 0000 Completed Startup
3. Grant 000 0000 Completed Startup
2. Accelerator/Incubator 21-May-2015 $50K Completed Startup
1. Accelerator/Incubator 26-Feb-2015 $50K $50K Completed Startup
To view Insightfil’s complete valuation and funding history, request access »

Insightfil Executive Team (3)

Name Title Board Seat Contact Info
Michael Trachtman Chief Technology Officer
Edward Acworth Ph.D Co-Founder & Chief Executive Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Insightfil Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
Healthbox Accelerator/Incubator Minority 000 0000 000000 0
MassVentures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Insightfil’s complete investors history, request access »